SentiSense
Ctrl+K
Quick tip: Press
to search stocks
A
ABBV
AbbVie Inc.
$230.11
-2.24 (-0.96%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$230.11
Live market price
P/E (TTM)
97.50
EPS: $2.36
P/S (TTM)
6.65
Price to Sales
TTM Quarters
4
Quarters included in TTM
Updated: 3/8/2026, 5:55:42 AM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
22.9M
% of Float
1.3%
Days to Cover
2.7
Avg Daily Vol
8.4M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
--
Leverage ratio
ROE (TTM)
--
Return on equity
Income Statement
Revenue
$61.16B
Cost of Revenue
$18.20B
Gross Profit
$42.96B
Operating Income
$15.07B
Net Income
$4.23B
EPS (Quarter)
$2.36
EPS (TTM)
--
Balance Sheet
Total Assets
$133.96B
Total Liabilities
$137.19B
Shareholders' Equity
$-3.23B
Current Assets
$29.06B
Current Liabilities
$43.29B
Cash & Equivalents
--
Long-Term Debt
$64.50B
Cash Flow
Operating Cash Flow
$19.03B
Investing Cash Flow
$-6.64B
Financing Cash Flow
$-12.72B
Free Cash Flow
$12.39B
Profitability Margins
Gross Margin
70.24%
Operating Margin
24.65%
Net Profit Margin
6.92%
ROA (TTM)
3.16%
ROE (TTM)
--
Data source: Polygon.io
Last updated: 3/8/2026, 5:55:42 AM
Company Profile
Symbol
ABBV
Market Cap
$406.87B
IPO Date
Dec 10, 2012
CEO
Robert A. Michael
Employees
57,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Read MoreSimilar Stocks
GILD
Gilead Sciences, Inc.
$143.93
-0.83%
REGN
Regeneron Pharmaceuticals, Inc.
$759.86
-0.66%
JNJ
Johnson & Johnson
$240.40
+0.32%
BMY
Bristol Myers Squibb Company
$60.29
-0.74%
AMGN
Amgen Inc.
$369.53
+0.53%